|
|
|
|
|
|
|
|
129th MAINE LEGISLATURE |
|
|
LD 793 |
|
LR 1130(03) |
|
|
|
An Act To Improve
Accountability of Opioid Manufacturers |
|
Fiscal Note for
Senate Amendment " " to Committee Amendment " " |
|
Sponsor: Pres. Jackson of Aroostook |
|
Fiscal Note Required: Yes |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fiscal Note |
|
|
|
|
|
|
|
| Potential reduction in revenue received - Opiod Use Disorder
Prevention and Treatment Fund |
|
|
|
|
|
|
|
| Fiscal Detail
and Notes |
|
|
|
|
|
|
Excluding
manufacturers of an opioid product or products from the annual license fee
for manufacturers of opioid medication under certain conditions may reduce
the amount of revenue deposited into the Opioid Use Disorder Prevention and
Treatment Fund from the annual license fee.
The amount cannot be estimated at this time. |
|
|
|
|
|
|
|